An overview on the delivery of antitumor drug doxorubicin by carrier proteins
- 1 July 2016
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 88, 354-360
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (NSERC)
This publication has 59 references indexed in Scilit:
- Antibiotic doxorubicin and its derivative bind milk β-lactoglobulinJournal of Photochemistry and Photobiology B: Biology, 2012
- Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum AlbuminsPLOS ONE, 2012
- Cationic polymers and their therapeutic potentialChemical Society Reviews, 2012
- Clinical impact of serum proteins on drug deliveryJournal of Controlled Release, 2012
- Impact of albumin on drug delivery — New applications on the horizonJournal of Controlled Release, 2012
- Protein Nanocapsules Containing Doxorubicin as a pH‐Responsive Delivery SystemSmall, 2011
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Polyamine Analogues Bind Human Serum AlbuminBiomacromolecules, 2007
- The SWISS-MODEL workspace: a web-based environment for protein structure homology modellingBioinformatics, 2005
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004